{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:04:35Z","timestamp":1789646675285,"version":"4.0.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113690","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T22:44:27Z","timestamp":1732661067000},"page":"113690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["YTHDF2 contributes to psoriasis by promoting proliferation and inflammatory response through regulation of the Wnt signaling pathway"],"prefix":"10.1016","volume":"144","author":[{"given":"Youlin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2024.113690_b0005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: a brief overview","volume":"21","author":"Raharja","year":"2021","journal-title":"Clin. Med. (Lond.)"},{"issue":"9997","key":"10.1016\/j.intimp.2024.113690_b0010","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"issue":"suppl 2","key":"10.1016\/j.intimp.2024.113690_b0015","doi-asserted-by":"crossref","first-page":"ii18","DOI":"10.1136\/ard.2004.033217","article-title":"Psoriasis: epidemiology, clinical features, and quality of life","volume":"64","author":"Langley","year":"2005","journal-title":"Ann Rheum Dis."},{"issue":"7397","key":"10.1016\/j.intimp.2024.113690_b0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11112","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.intimp.2024.113690_b0030","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.3390\/ijms21207571","article-title":"From 1957 to nowadays: a brief history of epigenetics","volume":"21","author":"Peixoto","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2024.113690_b0035","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113690_b0040","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molcel.2023.01.006","article-title":"RNA m6A methylation across the transcriptome","volume":"83","author":"Sendinc","year":"2023","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.intimp.2024.113690_b0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2024.113690_b0050","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41419-023-05790-4","article-title":"LncRNA UCA1 promotes keratinocyte-driven inflammation via suppressing METTL14 and activating the HIF-1\u03b1\/NF-\u03baB axis in psoriasis","volume":"14","author":"Hu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2024.113690_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106918","article-title":"Wilms' tumor 1-associating protein contributes to psoriasis by promoting keratinocytes proliferation via regulating cyclinA2 and CDK2","author":"Kong","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113690_b0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12935-021-01807-0","article-title":"The biological function of m6A reader YT-HDF2 and its role in human disease","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.intimp.2024.113690_b0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tig.2019.12.007","article-title":"Molecular mechanisms driving mRNA degradation by m6A modification","volume":"36","author":"Lee","year":"2020","journal-title":"Trends Genet."},{"issue":"1","key":"10.1016\/j.intimp.2024.113690_b0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13059-021-02308-z","article-title":"Histone l-actylation drives oncogenesis by facilitating m6A reader prote-in YTHDF2 expression in ocular melanoma","volume":"22","author":"Yu","year":"2021","journal-title":"Genome Biol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113690_b0075","doi-asserted-by":"crossref","first-page":"e848","DOI":"10.1002\/ctm2.848","article-title":"YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation","volume":"12","author":"Huang","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"9","key":"10.1016\/j.intimp.2024.113690_b0080","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.4049\/jimmunol.1403196","article-title":"Epigenetic downregulation of SFRP4 contributes to epidermal hyperplasia in psoriasis","volume":"194","author":"Bai","year":"2015","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113690_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.04.019","article-title":"YTHDF2 inhibition potentiates radiothera py antitumor efficacy","volume":"41","author":"Wang","year":"2023","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.intimp.2024.113690_b0090","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.18245","article-title":"Management of psoriasis as a systemic disease: what is the evidence?","volume":"182","author":"Korman","year":"2020","journal-title":"Br. J. Dermatol."},{"issue":"9583","key":"10.1016\/j.intimp.2024.113690_b0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2024.113690_b0100","first-page":"97","article-title":"Current developments in the immunology of psoriasis","volume":"93","author":"Gr\u00e4n","year":"2020","journal-title":"Yale J. Biol. Med."},{"issue":"20","key":"10.1016\/j.intimp.2024.113690_b0105","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.3390\/ijms232012672","article-title":"Reduction of methyltransferase-like 3-mediated RNA N6-methyladenosine exacerbates the development of psoriasis vulgaris in imiquimod-induced psoriasis-like mouse model","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2024.113690_b0110","article-title":"Transcriptome-wide m6A methylation in skin lesions from patients with psoriasis vulgaris","volume":"5","author":"Wang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113690_b0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40164-022-00269-y","article-title":"m6A binding protein YTHDF2 in cancer","volume":"11","author":"Chen","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113690_b0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13045-021-01124-z","article-title":"YTHDF2 facilitates UBXN1 mRNA decay by recognising METTL3-mediated m6A modification to activate NF-\u03baB and promote the malignant progression of glioma","volume":"14","author":"Chai","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113690_b0125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12943-020-01267-6","article-title":"YTHDF2 mediatesthe mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2024.113690_b0130","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1111\/jcmm.14531","article-title":"The pathological role of Wnt5a in psoriasis and psoriatic arthritis","volume":"23","author":"Tian","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"7","key":"10.1016\/j.intimp.2024.113690_b0135","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/jcp.25687","article-title":"Role of Wnt5a in the pathogenesis of inflammatory diseases","volume":"232","author":"Pashirzad","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113690_b0140","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1002\/jcp.26313","article-title":"Dickkop-f homolog 3 (DKK3): a candidate for detection and treatment of cancers?","volume":"233","author":"Hamzehzadeh","year":"2018","journal-title":"J. Cell. Physiol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924022124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924022124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:44:48Z","timestamp":1789645488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924022124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":27,"alternative-id":["S1567576924022124"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113690","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"YTHDF2 contributes to psoriasis by promoting proliferation and inflammatory response through regulation of the Wnt signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113690"}}